English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    O. O. Belov, N. G. Pshuk, A. M. Skrypnikov, L. O. Herasymenko, R. I. Isakov

    DYNAMICS OF PSYCHOPATHOLOGICAL SYMPTOMS IN THE POST-COVID-19 PERIOD


    About the author: O. O. Belov, N. G. Pshuk, A. M. Skrypnikov, L. O. Herasymenko, R. I. Isakov
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The dynamics of post-COVID-19 psychopathological manifestations in 31 men and 33 women were studied. It was established that fatigue (75 %), anxiety (70 %), cognitive dysfunction (69 %) and low mood (63 %) dominate the structure. The dynamics of depressive and anxiety changes were more pronounced in the first 6 months (from 63 % to 34 % and from 70 % to 48 %), and fatigue, cognitive impairment and insomnia – after 12 months (from 63 % to 28 %, from 63 % to 23 % and from 33 % to 22 %). In the early period, clinically defined depressive disorders were found in 36 % of patients, in the late period – in 8 %. The prevalence of psychopathological symptoms other than irritability was non-significantly higher among women; they were also found to have higher levels of depression and anxiety. Two years after COVID-19, symptoms of fatigue, cognitive dysfunction, dyssomnia, depression, and anxiety were present in 22 %, 17 %, 16 %, 14 %, and 13 %, respectively. Depression and anxiety rates normalized 12 months after COVID-19, faster in men than in women.
    Tags COVID-19,post-COVID-19 period,depression,anxiety,fatigue,cognitive dysfunction
    Bibliography
    • Boiko DI, Skrypnikov AM, Shkodina AD, Hasan MM, Ashraf GM, Rahman MH. Circadian rhythm disorder and anxiety as mental health complications in post‑COVID‑19. Environmental science and pollution research. 2022; 29: 28062–28069. http://repository.pdmu.edu.ua/handle/123456789/18560
    • Calabria M, García-Sánchez C, Grunden N. Post-COVID-19 fatigue: The contribution of cognitive and neuropsychiatric symptoms. J. Neurol. 2022; 269: 3990–3999. doi: 10.1007/s00415-022-11141-8.
    • Chen AK, Wang X, McCluskey LP. Neuropsychiatric sequelae of long COVID-19: Pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA. Brain Behav. Immun. Health. 2022; 24: 100491. doi:  10.1016/j.bbih.2022.100491.
    • Hamilton M. A rating scale for depression by Max Hamilton. Journal of Neurology, Neurosurgery, Psychiatry. 1960; 23: 56–62. doi: 10.1136/jnnp.23.1.56.
    • Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 1959; 32: 50–55. doi:  10.1111/j.2044-8341.1959.tb00467.x.
    • National Institute of Clinical Excellence (NICE) COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute of Clinical Excellence; London, UK: 2022.
    • Ohira M, Sano T, Takao M. Clinical features of patients who visited the outpatient clinic for long COVID in Japan. eNeurologicalSci. 2022; 28: 100418. doi: 10.1016/j.ensci.2022.100418.
    • Paez AF, Nicolalde B, Esquetini-Vernon C, Lara-Taranchenko Y, Zambrano K, Ocampo J, et al. Psychiatric disorders in Post-acute COVID-syndrome (PDPACS): Recommendations for health care professionals. Eur Neuropsychopharmacol. 2022; 58: 100–102. doi: 10.1016/j.euroneuro.2022.03.003.
    • Pavli A, Theodoridou M, Maltezou HC. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch. Med. Res. 2021; 52: 575–581. doi: 10.1016/j.arcmed.2021.03.010.
    • Penninx BWJH. Psychiatric symptoms and cognitive impairment in “Long COVID”: The relevance of immunopsychiatry. World Psychiatry. 2021; 20: 357–358. doi: 10.1002/wps.20913.
    • Sampogna G, Di Vincenzo M, Giallonardo V, Perris F, Volpicelli A, Del Vecchio V, et al. The Psychiatric Consequences of Long-COVID: A Scoping Review. J Pers Med. 2022; 12(11): 1767. doi: 10.3390/jpm12111767.
    • Stallmach A, Kesselmeier M, Bauer M. Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: Is there a specific constellation? Infection. 2022; 50: 661–669. doi: 10.1007/s15010-021-01733-3.
    • Stefano GB, Ptacek R, Ptackova H, Martin A, Kream RM. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce ‘Brain Fog’ and Results in Behavioral Changes that Favor Viral Survival. Med. Sci. Monit. 2021; 27: e930886. doi: 10.12659/MSM.930886.
    • Zakia H, Pradana K, Iskandar S. Risk factors for psychiatric symptoms in patients with long COVID: A systematic review. PLoS One. 2023. 18(4): e0284075. doi: 10.1371/journal.pone.0284075.
    • Zawilska JB, Kuczyńska K. Psychiatric and neurological complications of long COVID. J Psychiatr Res. 2022. 156:349-360. doi: 10.1016/j.jpsychires.2022.10.045.
    Publication of the article «World of Medicine and Biology» №1(87), 2024 year, 031-035 pages, index UDK 616-036.21:371.711-08
    DOI 10.26724/2079-8334-2024-1-87-31-35